Silo Pharma Inc (SILO)

Currency in USD
6.190
+0.145(+2.40%)
Closed·
6.040-0.150(-2.42%)
·
Advertisement
SILO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.9406.190
52 wk Range
0.38515.150
Key Statistics
Prev. Close
6.19
Open
5.96
Day's Range
5.94-6.19
52 wk Range
0.385-15.15
Volume
354.93K
Average Volume (3m)
282.92K
1-Year Change
-34.4974%
Book Value / Share
6.02
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SILO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

Silo Pharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
29/05/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare SILO to Peers and Sector

Metrics to compare
SILO
Peers
Sector
Relationship
P/E Ratio
−1.4x−2.4x−0.4x
PEG Ratio
−0.02−0.010.00
Price/Book
1.2x1.8x2.6x
Price / LTM Sales
93.1x379.1x3.0x
Upside (Analyst Target)
-191.5%51.8%
Fair Value Upside
Unlock−16.0%7.2%Unlock

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company’s two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company’s research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
93.08K8.58%562.66K
Other Institutional Investors
-22.70K-2.09%-137.20K
Public Companies & Retail Investors
1.01M93.51%6.13M
Total
1.08M100.00%6.56M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
AdvisorShares Trust - AdvisorShares Psychedelics ETF6.32%68,547414
AdvisorShares Investments, LLC4.08%44,264268

People Also Watch

74.4100
SLGL
+1.24%
0.72
KIDZ
-12.23%
15.19
MPAA
-2.19%
1.620
TURB
+5.88%
0.820
SUGP
-3.98%

FAQ

What Is the Silo Pharma (NASDAQ: SILO) Share Price Today?

The Silo Pharma stock price today is 6.190 USD.

What Stock Exchange Does Silo Pharma (SILO) Trade On?

Silo Pharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Silo Pharma?

The stock symbol (also called a 'ticker') for Silo Pharma is "SILO."

What Is the Current Silo Pharma Market Capitalisation?

As of today, Silo Pharma (NASDAQ: SILO) market cap is 6.560M USD.

What Is Silo Pharma's (SILO) Earnings Per Share (TTM)?

The Silo Pharma EPS is currently -6.797 (Trailing Twelve Months).

When Is the Next Silo Pharma Earnings Date?

Silo Pharma's next earnings report will be released on 02/09/2026.

Is SILO a Buy or Sell From a Technical Analyst Perspective?

Based on today's Silo Pharma moving averages and other technical indicators, the daily buy/sell signal for SILO stock is Neutral.

How Many Times Has Silo Pharma Stock Split?

Silo Pharma has split 2 times. (See the SILO stock split history page for full effective split date and price information.)

How Many Employees Does Silo Pharma Have?

Silo Pharma has 3 employees, based on their latest Companies House report.

What is the current trading status of Silo Pharma (NASDAQ: SILO)?

As of 30/06/2026, Silo Pharma (SILO) is trading at a share price of 6.190 USD, with a previous close of 6.190 USD. The stock has fluctuated within a day range of 5.940 USD to 6.190 USD, while its 52-week range spans from 0.385 USD to 15.150 USD.

What Is the SILO Premarket Price?

SILO's last pre-market stock price is 5.769 USD. The pre-market share volume is 120.000, and the stock has decreased by -0.276, or -4.570%.

What Is the SILO After Hours Price?

SILO's last after hours stock price is 6.040 USD, the stock has decreased by -0.150, or -2.420%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.